These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


227 related items for PubMed ID: 27743168

  • 1. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.
    Ding X, Yang Y, Sun Y, Xu W, Su B, Zhou X.
    Clin Transl Oncol; 2017 May; 19(5):546-552. PubMed ID: 27743168
    [Abstract] [Full Text] [Related]

  • 2. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
    Chi Y, Jin Q, Liu X, Xu L, He X, Shen Y, Zhou Q, Zhang J, Jin M.
    Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C.
    J Exp Clin Cancer Res; 2016 May 10; 35():76. PubMed ID: 27164951
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D, Wang Y, Ren K, Han X.
    Exp Cell Res; 2018 Jan 01; 362(1):172-179. PubMed ID: 29133127
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo.
    Zeng Y, Zhu J, Shen D, Qin H, Lei Z, Li W, Liu Z, Huang JA.
    Oncotarget; 2017 May 09; 8(19):30817-30829. PubMed ID: 28199217
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC, Li SJ, Zhang F, Pan JY, Wang L, Yang CL, Xi YY, Li de J.
    Oncotarget; 2016 Apr 19; 7(16):21510-26. PubMed ID: 26909600
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D, Wang JJ, Li JS, Xu QY.
    Oncol Res; 2018 May 07; 26(4):519-528. PubMed ID: 28734041
    [Abstract] [Full Text] [Related]

  • 16. MiR-598 Suppresses Invasion and Migration by Negative Regulation of Derlin-1 and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Yang F, Wei K, Qin Z, Liu W, Shao C, Wang C, Ma L, Xie M, Shu Y, Shen H.
    Cell Physiol Biochem; 2018 May 07; 47(1):245-256. PubMed ID: 29768262
    [Abstract] [Full Text] [Related]

  • 17. The candidate oncogene (MCRS1) promotes the growth of human lung cancer cells via the miR-155-Rb1 pathway.
    Liu M, Zhou K, Huang Y, Cao Y.
    J Exp Clin Cancer Res; 2015 Oct 14; 34():121. PubMed ID: 26467212
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.